Dell Faulkingham, CCO at Akebia Therapeutics, Inc. (AKBA), sold 6,749 shares at $3.40 ($23K) on 2021-03-01, disclosed to the SEC on 2021-03-02.
Open-market sale of $23k AKBA by CCO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKBA | SELL | 2020-06-02 | $149K | — | Filing → |